SEARCH
Toggle navigation
HOME
COMPANY
TECHNOLOGY
IMMUNOBODY
MODITOPE
AVIDIMAB
COVIDITY
SCIENTIFIC PAPERS & POSTERS
PRODUCTS
PRODUCT PIPELINE
SCIB1
SCIB2
Modi-1
Modi-2
INVESTORS
COMPANY PROFILE
ADVISORS
CORPORATE GOVERNANCE
DOCUMENTS & PRESENTATIONS
SHARE INFO
FINANCIAL INFO
2020 CAPITAL RAISE
REGULATORY NEWS
REGULATORY NEWS ARCHIVE
NEWS
LATEST NEWS
INTERVIEWS
MEDIA COVERAGE
WEBCASTS
YEAR - 2020
YEAR - 2019
YEAR - 2018
YEAR - 2017
YEAR - 2016
YEAR - 2015
CONTACT US
SEARCH
INVESTORS
HOME
COMPANY
TECHNOLOGY
IMMUNOBODY
MODITOPE
AVIDIMAB
COVIDITY
SCIENTIFIC PAPERS & POSTERS
PRODUCTS
PRODUCT PIPELINE
SCIB1
SCIB2
Modi-1
Modi-2
INVESTORS
COMPANY PROFILE
ADVISORS
CORPORATE GOVERNANCE
DOCUMENTS & PRESENTATIONS
SHARE INFO
FINANCIAL INFO
2020 CAPITAL RAISE
REGULATORY NEWS
REGULATORY NEWS ARCHIVE
NEWS
LATEST NEWS
INTERVIEWS
MEDIA COVERAGE
WEBCASTS
YEAR - 2020
YEAR - 2019
YEAR - 2018
YEAR - 2017
YEAR - 2016
YEAR - 2015
CONTACT US
Investor Information
Scancell Holdings PLC is an AIM listed company
Advisors
Share Information
Corporate Governance
Financial Information
Documents & Presentations
Regulatory News
Press Releases
Scancell announces selection of COVID-19 vaccine candidate, SN14
To download
click here
Director Dealing
To download
click here
Director Dealing
To download
click here
View all posts
»